158 related articles for article (PubMed ID: 28588939)
1. Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults.
Murray M; Cattamanchi A; Denkinger C; Van't Hoog A; Pai M; Dowdy D
BMJ Glob Health; 2016; 1(2):e000064. PubMed ID: 28588939
[TBL] [Abstract][Full Text] [Related]
2. Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis.
van't Hoog AH; Cobelens F; Vassall A; van Kampen S; Dorman SE; Alland D; Ellner J
PLoS One; 2013; 8(12):e82786. PubMed ID: 24367555
[TBL] [Abstract][Full Text] [Related]
3. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
Li J; Yip BHK; Leung C; Chung W; Kwok KO; Chan EYY; Yeoh E; Chung P
PLoS One; 2018; 13(1):e0189531. PubMed ID: 29293514
[TBL] [Abstract][Full Text] [Related]
4. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
[TBL] [Abstract][Full Text] [Related]
5. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults.
Calderwood CJ; Reeve BW; Mann T; Palmer Z; Nyawo G; Mishra H; Ndlangalavu G; Abubakar I; Noursadeghi M; Theron G; Gupta RK
J Infect; 2023 Jan; 86(1):24-32. PubMed ID: 36375640
[TBL] [Abstract][Full Text] [Related]
8. A cost-benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns.
Donkeng-Donfack VF; Tchatchueng-Mbougua JB; Abanda NN; Ongboulal SM; Djieugoue YJ; Kamdem Simo Y; Mekemnang Tchoupa M; Bekang Angui F; Kuate Kuate A; Mbassa V; Mvondo Abeng Belinga E; Eyangoh S
BMC Infect Dis; 2022 Mar; 22(1):219. PubMed ID: 35246071
[TBL] [Abstract][Full Text] [Related]
9. Head-to-head comparison of diagnostic accuracy of TB screening tests: Chest-X-ray, Xpert TB host response, and C-reactive protein.
Crowder R; Thangakunam B; Andama A; Christopher DJ; Dalay V; Dube-Nwamba W; Kik SV; Van Nguyen D; Nhung NV; Phillips PP; Ruhwald M; Theron G; Worodria W; Yu C; Nahid P; Cattamanchi A; Gupta-Wright A; Denkinger CM;
medRxiv; 2024 Jun; ():. PubMed ID: 38947093
[TBL] [Abstract][Full Text] [Related]
10. Screening tests for active pulmonary tuberculosis in children.
Vonasek B; Ness T; Takwoingi Y; Kay AW; van Wyk SS; Ouellette L; Marais BJ; Steingart KR; Mandalakas AM
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013693. PubMed ID: 34180536
[TBL] [Abstract][Full Text] [Related]
11. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation.
Menzies NA; Cohen T; Lin HH; Murray M; Salomon JA
PLoS Med; 2012; 9(11):e1001347. PubMed ID: 23185139
[TBL] [Abstract][Full Text] [Related]
12. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
[TBL] [Abstract][Full Text] [Related]
13. Computer-aided X-ray screening for tuberculosis and HIV testing among adults with cough in Malawi (the PROSPECT study): A randomised trial and cost-effectiveness analysis.
MacPherson P; Webb EL; Kamchedzera W; Joekes E; Mjoli G; Lalloo DG; Divala TH; Choko AT; Burke RM; Maheswaran H; Pai M; Squire SB; Nliwasa M; Corbett EL
PLoS Med; 2021 Sep; 18(9):e1003752. PubMed ID: 34499665
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of GeneXpert Omni compared with GeneXpert MTB/Rif for point-of-care diagnosis of tuberculosis in a low-resource, high-burden setting in Eastern Uganda: a cost-effectiveness analysis based on decision analytical modelling.
Ejalu DL; Irioko A; Kirabo R; Mukose AD; Ekirapa E; Kagaayi J; Namutundu J
BMJ Open; 2022 Aug; 12(8):e059823. PubMed ID: 35998960
[TBL] [Abstract][Full Text] [Related]
15. Economic analysis of different throughput scenarios and implementation strategies of computer-aided detection software as a screening and triage test for pulmonary TB.
Bashir S; Kik SV; Ruhwald M; Khan A; Tariq M; Hussain H; Denkinger CM
PLoS One; 2022; 17(12):e0277393. PubMed ID: 36584194
[TBL] [Abstract][Full Text] [Related]
16. Cost-Utility Analysis of Molecular Testing for Tuberculosis Diagnosis in Suspected Pulmonary Tuberculosis in Thailand.
Chitpim N; Jittikoon J; Udomsinprasert W; Mahasirimongkol S; Chaikledkaew U
Clinicoecon Outcomes Res; 2022; 14():61-73. PubMed ID: 35140485
[TBL] [Abstract][Full Text] [Related]
17. Impact of early chest radiography on delay in pulmonary tuberculosis case notification in Ethiopia.
Mohammed H; Oljira L; Roba KT; Ngadaya E; Tesfaye D; Manyazewal T; Yimer G
Int J Mycobacteriol; 2021; 10(4):364-372. PubMed ID: 34916453
[TBL] [Abstract][Full Text] [Related]
18. Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert
Pallas SW; Courey M; Hy C; Killam WP; Warren D; Moore B
Appl Health Econ Health Policy; 2018 Aug; 16(4):537-548. PubMed ID: 29862440
[TBL] [Abstract][Full Text] [Related]
19. Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.
Vassall A; van Kampen S; Sohn H; Michael JS; John KR; den Boon S; Davis JL; Whitelaw A; Nicol MP; Gler MT; Khaliqov A; Zamudio C; Perkins MD; Boehme CC; Cobelens F
PLoS Med; 2011 Nov; 8(11):e1001120. PubMed ID: 22087078
[TBL] [Abstract][Full Text] [Related]
20. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.
Shapiro AE; Ross JM; Yao M; Schiller I; Kohli M; Dendukuri N; Steingart KR; Horne DJ
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013694. PubMed ID: 33755189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
